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a  b  s  t  r  a  c  t
Histaminergic  ﬁbers  are  present  in the  molecular  and  granular  layers  of  the  cerebellum  and  have  high
density  in  the  vermis  and  ﬂocculus.  Evidence  indicates  that  the  cerebellar  vermis  is  involved  in  memory
consolidation.  Recently,  we  demonstrated  that  when  histamine  is microinjected  into  the cerebellar  ver-
mis it  results  in  impaired  emotional  memory  consolidation  in mice  that  are  submitted  to  the elevated
plus  maze  (EPM).  This  study  investigated  whether  histamine  impairment  was  mediated  by  the H1 or  H2
receptors.  The  cerebellar  vermis  of male  mice  (Swiss  Albino)  were  implanted  using  a guide  cannula.  Three
days after  recovery,  behavioral  tests  were  performed  in the  EPM  on two consecutive  days  (Trial 1  and  Trial
2). Immediately  after  exposure  to the EPM  (Trial  1),  animals  received  a microinjection  of histaminergic
drugs.  In Experiment  1, saline  (SAL)  or histamine  (HA, 4.07  nmol/0.1  l) was  microinjected  5 min  after
pretreatment  with  the  H1 antagonist  chlorpheniramine  (CPA,  0.16  nmol/0.1  l) or SAL. In Experiment  2,
SAL  or  HA  was  microinjected  into  the  mice 5  min  after  pretreatment  with  the  H2 antagonist  ranitidine
(RA,  2.85  nmol/0.1  l) or SAL.  Twenty-four  hours  later,  the  mice  were  re-exposed  to  the  EPM (Trial 2)
under  the same  experimental  conditions  but  did  not  receive  an  injection.  On  both  days,  the  test  sessions
were  recorded  to enable  analysis  of  the  behavioral  measures.  The  decrease  in open  arm  exploration  (%
entries  and  %  time  spent  in  the  open  arms)  in  Trial 2 relative  to Trial  1  was  used as a measure  of learning
and  memory.  The  data  were  analyzed  using  the  two-way  analysis  of variance  (ANOVA)  and  Duncan’s
tests.  In Experiment  1, the  Duncan’s  test  indicated  that  the  mice  entered  the  open  arms  less  often  (%OAE)
and  spent  less  time  in the  open  arms  (%OAT)  in  Trial  2 after  being  microinjected  with  SAL  + SAL, SAL  + CPA
and  CPA  +  HA.  However,  the  animals  that received  SAL  + HA did  not  enter  the  open  arms  less  frequently
or  spend  less  time  in  them,  which  was  signiﬁcantly  different  from  the  CPA  + HA group.  The results  of
Experiment  2 demonstrated  that  the %OAE  and  %OAT  in  Trial  2  were  different  from  Trial  1 for  the  groups
that were  microinjected  with  SAL  +  SAL  and  SAL +  RA.  The  animals  that  were  microinjected  with  RA  +  HA
or with  SAL  + HA  did not  show  a reduction  in %OAE.  These  results  demonstrate  that  the  animals  treated
with  HA  did  not  avoid  the  open  arms  less  on retesting  and  indicated  that  CPA  did  not  alter  the  behavior
parameters  but  did  revert  the histamine-induced  impairment  of memory  consolidation.  Furthermore,
the  H2 antagonist  RA, at the  dose  used  in this  study,  did  not  affect  memory  consolidation  and  failed  to
revert histamine-induced  impairment.
© 2012 Elsevier Inc. Open access under the Elsevier OA license.Abbreviations: EPM, elevated plus maze; SAL, saline; HA, histamine; CPA,
hlorpheniramine; RA, ranitidine; %OAE, percentage of open arms entries; %OAT,
ercentage of open arm time; CNS, central nervous system; OAE, open arm entries;
AE,  enclosed arm entries; OAT, time spent in the open arms; EAT, time spent in the
nclosed arms; CT, time spent in the central area; %EAT, percentage of time spent in
he  enclosed arms; SAP, the number of stretched-attend postures; HD, head dipping.
∗ Corresponding author at: Physiotherapy Department, Federal University of São
arlos, Rodovia Washington Luís, Km 235, Bairro Monjolinho, CEP: 13565-905, São
arlos, SP, Brazil. Tel.: +55 16 3351 8628; fax: +55 16 3361 2081.
E-mail address: mattioli@ufscar.br (R. Mattioli).
361-9230 © 2012 Elsevier Inc. 
ttp://dx.doi.org/10.1016/j.brainresbull.2012.09.003
Open access under the Elsevier OA license.1. Introduction
Histamine is an important neurotransmitter–neuromodulator
in the central nervous system (CNS). Histaminergic neurons are
located exclusively in the tuberomammillary nucleus. From there,
they project to all regions of the brain, including the cerebel-
lum, which contains high density of histaminergic terminations in
the vermis and ﬂocculus (Panula et al., 1989; Wada et al., 1991).
Histamine-immunoreactive ﬁbers are located in the molecular and
granular layers of the cerebellum in several species, including
humans. These ﬁbers run parallel to the Purkinje cell layer after
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raversing perpendicular to it (Hass and Panula, 2003; Panula et al.,
993).
Autoradiographic mapping and in situ hybridization experi-
ents demonstrated the presence of H1 and H2 receptors in the
at cerebellar cortex and deep in the cerebellar nuclei (Arrang
t al., 1995; Pollard et al., 1993). These studies suggest that his-
amine may  play an important role in modulating the excitability
f cerebellar neurons. The Purkinje cells of the cerebellar cortex
nd the neurons in the nucleus interpositus all exhibit H2 receptor-
ediated excitatory responses when exposed to a histamine bath
erfusion (Shen et al., 2002). Granule cells are excited through the
ctivation of the H1 and H2 receptors (Li et al., 1999; Tian et al.,
000).
Recently, evidence has been presented indicating that the cere-
ellum, in addition to being a motor coordination center, is also
nvolved in modulation of emotional behavior (Schmahmann et al.,
007; Strata et al., 2011; Tavano and Borgatti, 2010). Additionally,
he vermal part of the cerebellum has been implicated in emotional
r fear-related behaviors (Sacchetti et al., 2009; Storozheva, 2009).
ccording to Sacchetti et al. (2005),  the fact that there is a functional
nterconnection between the cerebellar vermis and the hypothal-
mus, amygdala, and hippocampus suggests that the cerebellum
ay  play a role in the integrated network that regulates emotional
ehavior.
Studies have related the cerebellar vermis to emotional mem-
ry consolidation (Sacchetti et al., 2002; Storozheva, 2009). In one
tudy, inactivation of the vermis caused amnesic effects after a fear-
onditioning task (Sacchetti et al., 2002). Other ﬁndings indicate
hat after training the cerebellar vermis is selectively involved in
ong-term memory formation for certain types of defense behaviors
Storozheva, 2009). Thus, the participation of the vermis in emo-
ional memory may  be independent of its role in sensory or motor
rocesses, and the vermis may  represent an interface between sen-
ory stimuli, the emotional state, and motor responses (Sacchetti
t al., 2005, 2009).
The neural histaminergic system is involved in several behav-
oral and neurobiological functions, such as arousal, food intake,
otor activity, and nociception (Brown et al., 2001; Hass and
anula, 2003). However, the part histaminergic circuits play in
nemonic effects is complex. Histamine seems to have different
ffects in distinct brain regions and may  have modulatory effects
hat differ according to the memory type. The exact role of this
eurotransmitter in learning processes and memory consolidation,
he action of the receptor subtypes and how they affect key cir-
uits related to a speciﬁc memory system are not well understood
Köhler et al., 2011).
Histaminergic modulation of learning and memory was studied
sing lesions and pharmacological interventions in the tubero-
ammillary nucleus and other decisive brain regions. However, the
ole of the cerebellar histaminergic system on memory has not been
nvestigated. In our ﬁrst study, microinjection of histamine into
he cerebellar vermis demonstrated that the cerebellar histamin-
rgic system is involved in the process of consolidation of emotional
emory. These results indicated that there was a dose-dependent
nhibition of memory consolidation when histamine was injected
nto the cerebellar vermis in mice re-exposed to the elevated plus
aze (Gianlorenc¸ o et al., 2011a).  Therefore, in the present study
e investigated whether histamine impairment was  mediated by
he H1 and/or H2 receptors.
. Materials and methods.1. Subjects
Male Swiss mice (Federal University of São Carlos, UFSCar, SP, Brazil) weigh-
ng  25–35 g at the beginning of the experiments were housed in polypropylene
ages (31 cm × 20 cm × 13 cm) in groups of ﬁve and were maintained under a 12 hch Bulletin 89 (2012) 197– 202
light cycle (lights on at 7:00 a.m.) in a controlled environment at a temperature of
23  ± 1 ◦C and a humidity level of 50 ± 5%. Food and drinking water were provided
ad  libitum, except during the brief test periods. All mice were experimentally naive,
and  the experimental sessions were conducted during the light period of the cycle
(9:00–13:00 h).
2.2. Drugs
Histamine dihydrochloride, the H1 receptor antagonist, chlorpheniramine
maleate salt and the H2 receptor antagonist ranitidine hydrochloride (Sigma Chem-
ical  Co., USA) were prepared in a vehicle of physiological saline. Saline solution
was  used as an experimental control. The doses were based on previous research
(Gianlorenc¸ o et al., 2011a)  and on pilot work in our laboratory. The substances were
coded, and the experimenter was blinded to the codes when the tests and behavioral
analysis were performed.
2.3. EPM apparatus
The EPM used was similar to the one originally described by Lister (1987).
The  EPM consisted of two open arms (30 cm ×5 cm × 0.25 cm)  and two enclosed
arms (30 cm × 5 cm × 15 cm)  that were connected to a common central platform
(5 cm × 5 cm). The apparatus was made of crystal acrylic and was raised 38.5 cm
above ﬂoor level.
2.4. Stereotaxic surgery and drug infusion
Mice were intraperitoneally anesthetized using ketamine hydrochloride
(100 mg/kg) and xylazine (10 mg/kg) solution in association with local anesthe-
sia (3% lidocaine with norepinephrine 1:50,000) and were placed in a Stoelting
stereotaxic instrument. A single, 7 mm,  stainless steel guide cannula (25 gauge) was
implanted in the cerebellar vermis according to the following coordinates from the
mouse brain atlas (Franklin and Paxinos, 2001): 6.5 mm posterior to the bregma,
0  mm lateral to the midline, and 2.0 mm ventral to the skull surface. The guide can-
nula was  ﬁxed to the skull using dental acrylic and jeweler’s screws. A dummy
cannula (33 gauge stainless steel wire) was inserted into the guide cannula at the
time of surgery to reduce the incidence of occlusion. Postoperative analgesia was
provided for 3 days by adding acetaminophen (200 mg/ml) to the drinking water in
a  ratio of 0.2 ml  acetaminophen to 250 ml water (i.e., the ﬁnal concentration was
0.16 mg/ml).
Saline and drug solutions were infused into the cerebellar vermis using a
microinjection unit (33 gauge cannula; Insight Equipamentos Cientíﬁcos Ltda,
Brazil), which extended 2.0 mm beyond the tip of the guide cannula. The microin-
jection unit was  attached to a 5-l  Hamilton microsyringe via polyethylene tubing
(PE-10), and the administration was controlled by an infusion pump (Insight Equipa-
mentos Cientíﬁcos Ltda, Brazil) that was programmed to deliver a volume of 0.1 l
over a period of 60 s. The microinjection procedure consisted of gently restrain-
ing  the animal, inserting the injection unit, infusing the solution, and keeping the
injection needle in situ for a further 60 s to avoid reﬂux. Conﬁrmation of successful
infusion was  obtained by monitoring the movement of a small air bubble inside the
PE-10 tubing.
2.5. General conditions and data collection
Three days after surgery, the animals were transported to the experimental
room and left undisturbed for at least 1 h before testing to facilitate adaptation.
The  test was performed on two  consecutive days, and the trials in the EPM were
denoted Trial 1 and Trial 2. Mice were individually placed on the central platform
of  the maze facing the open arm and were able to explore the maze for 5 min.
In Trial 1, immediately after exposure to the EPM, the animals received a
microinjection of the drugs. In Experiment 1, saline (SAL) or 4.07 nmol histamine
(HA)  was microinjected 5 min  after pretreatment with 0.16 nmol chlorpheniramine
(CPA). In Experiment 2, SAL or 4.07 nmol HA was  microinjected 5 min  after pretreat-
ment with 2.85 nmol ranitidine (RA). Twenty-four hours later (Trial 2), the mice were
re-exposed to the EPM under the same experimental conditions as in Trial 1 with
the exception that they did not receive an injection. Between subjects, the maze was
thoroughly cleaned with 5% ethanol and a dry cloth. All tests were conducted under
moderate illumination (77 lx) as measured on the central platform of the EPM and
in  an environment isolated from the rest of the room by a black protective curtain.
All sessions were video recorded with a digital camera that was  linked to a
computer in an adjacent room. Images were analyzed by a highly trained observer
using X-PLO-RAT, which is an ethological analysis software package developed at
the Laboratory of Exploratory Behavior USP/Ribeirao Preto (Garcia et al., 2005).
Behavioral parameters were deﬁned in a way  that was consistent with previous
studies (Lister, 1987; Rodgers and Johnson, 1995) and included the following obser-
vations: the frequency of open- and enclosed-arm entries (OAE and EAE) (an entry
was deﬁned as the entry of all four of an animal’s paws into an arm) and the total
amount of time spent in the open arms (OAT), enclosed arms (EAT), and central
area (CT). These data were used to calculate the percentage of open arm entries
(%OAE = (open entries/open + enclosed entries) × 100), the percentage of time spent
in  the open arms (%OAT = (open time/300) × 100), and the percentage of time spent
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maller than the total number of mice because of overlap. (B) Photomicrograph sho
n  the enclosed arms (%EAT = (enclosed time/300) × 100). The number of stretched-
ttend postures (SAP; exploratory posture in which the body stretches forward and
hen retracts to its original position without any forward locomotion), immobility
ime (stillness but some movement of the chest), and the frequency of head dipping
HD; exploratory movement of head/shoulders over the sides of the maze) were
lso scored. Total SAP was  considered a primary index of risk assessment, and head
ipping was considered an index of exploratory behavior (Rodgers et al., 1997).
.6. Histology
At the end of testing, all animals received a 0.1 l infusion of 1% methylene blue
ccording to the microinjection procedure described above. The animals received
n  anesthetic overdose, their brains were removed and the injection sites were ver-
ﬁed histologically according to the atlas of Franklin and Paxinos (2001). Data from
nimals with injection sites outside the cerebellar vermis were excluded from the
tudy. The ﬁnal sample size of each cohort ranged between 9 and 13. Histology con-
rmed that a total of 87 mice had accurate cannula placement mainly in the anterior
nd  central vermis in the lobules V and VI (Fig. 1).
.7. Statistical analysisAll results were initially analyzed using the Levene’s test for homogeneity of
ariance. The data were analyzed using the two-way repeated measures ANOVA
factor 1: treatment; factor 2: trial). When differences were indicated by signiﬁcant
 values, they were further analyzed using Duncan’s multiple range tests. A p value
f  less than 0.05 was considered signiﬁcant.
ig. 2. Effects of the combined injection of the H1 antagonist CPA (0.16 nmol) and histam
ercentage of open arm time (%OAT) in Trials 1 and 2 in the EPM. Data are presented as 
roup  in Trial 2, Duncan’s test.of microinfusion (ﬁlled circles) into the cerebella of mice. The number of points is
a typical injection site (indicated by an arrow) in the cerebellar vermis.
2.8. Ethics
The experiments performed as part of in this study were approved by the Animal
Ethics Commission of the Federal University of Sao Carlos (CEEA 049/09) and are
in  compliance with the norms of the Brazilian Neuroscience and Behavior Society
(SBNeC), which are based on the US National Institutes of Health Guide for Care and
use of Laboratory Animals.
3. Results
3.1. Experiment 1: pretreatment with the H1 receptor antagonist
CPA prevents the HA-induced impairment of memory
consolidation
As summarized in Fig. 2A and B and Table 1, the two-way ANOVA
revealed no signiﬁcant differences among groups in Trial 1 for all
the measures analyzed. However, there were differences in the
%OAE between trials (F1,38 = 22.89, p = 0.00003). The post hoc Dun-
can’s test indicated that the mice entered the open arms less often
in Trial 2 compared to Trial 1 when microinjected with SAL + SAL
(p = 0.007), CPA + SAL (p = 0.04), and CPA + HA (p = 0.0004). However,
no change in the percentage %OAE was observed in the animals
ine (4.07 nmol): (A) on the percentage of open arm entries (%OAE) and (B) on the
the mean ± SEM. n = 9–11. *p < 0.05 Trial 2 versus Trial 1; #p < 0.05 versus CPA + HA
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Table  1
Effects of the combined injection of the H1 antagonist CPA (0.16 nmol) and histamine (4.07 nmol) on the behavior of mice in Trials 1 and 2 in the EPM.
SAL + SAL CPA + SAL CPA + HA SAL + HA
T1 T2 T1 T2 T1 T2 T1 T2
OAE 6.5 ± 0.7 2,7 ± 0.6* 7.4 ± 1.5 3.9 ± 0.8* 5.9 ± 1.2 1.7 ± 0.5* 5.7 ± 1.0 5.9 ± 0.9+,#
OAT 99.2 ± 21.6 42.6 ± 14.8* 77.8 ± 12.4 35.3 ± 6.3* 71.3 ± 14.6 14.1 ± 4.4* 86.4 ± 21.1 69.7 ± 11.7#
EAE 9.0 ± 1.3 9.3 ± 1.9 11.3 ± 1.3 11.7 ± 1.8 8.2 ± 0.7 8.9 ± 0.9 10.9 ± 0.7 11.7 ± 2.9
EAT 11.8 ±  16.6 193.6 ± 17.4* 114.3 ± 9.1 165.1 ± 12.9* 112.1 ± 9.7 217.3 ± 9.2* 132.0 ± 17.1 181.4 ± 12.9*
%EAT 37.3 ± 5.5 64.5 ± 5.8* 38.1 ± 3.0 55.0 ± 4.3* 37.4 ± 3.2 72.4 ± 3.1* 44.0 ± 5.7 60.5 ± 4.3*
CT 89.0 ± 10.3 63.8 ± 10.6 107.9 ± 6.1 99.6 ± 11.6 116.6 ± 15.5 68.6 ± 8.7* 81.6 ± 11.8 48.9 ± 7.4
SAP  6.7 ± 1.3 5.7 ± 1.8 8.8 ± 1.3 4.3 ± 0.8* 7.4 ± 1.2 4.2 ± 0.8 7.2 ± 1.1 6.7 ± 1.0
HD  6.9 ± 0.9 1.6 ± 0.6* 4.1 ± 0.8 0.9 ± 0.4* 4.9 ± 1.1 0.6 ± 0.4* 2.6 ± 1.1 1.6 ± 0.7
Immobility 0.2 ± 0.2 0.1 ± 0.1 0.0 ± 0.0 0.0 ± 0.0 0.0 ± 0.0 0.0 ± 0.0 0.0 ± 0.0 0.9 ± 0.9
The data are presented as the mean values (±SEM). Immediately after exposure to the EPM (T1), the animals received a microinjection of the following drugs: SAL + SAL;
CPA  + SAL (CPA 0.16 nmol/0.1 l and saline); CPA + HA (CPA 0.16 nmol/0.1 l and HA 4.07 nmol/0.1 l); SAL + HA (saline and HA 4.07 nmol/0.1 l). OAE (number of open arm
entries), OAT (time spent in the open arms), EAE (number of enclosed arm entries), EAT (time spent in the enclosed arms), %EAT (percentage of time in enclosed arms), CT
(central platform time), SAP (frequency of stretched-attend postures), HD (frequency of head dipping), and immobility (total time). The second is the unit measure of time.
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sp < 0.05 Trial 2 versus Trial 1.
+ p < 0.05 versus control group (SAL + SAL) in Trial 2.
# p < 0.05 versus the CPA + HA group in Trial 2.
hat received SAL + HA (p = 0.84) and the %OAE was  signiﬁcantly
ifferent from the CPA + HA group (p = 0.007) (Fig. 2A).
Fig. 2B shows the %OAT for the ﬁrst and second sessions.
he ANOVA revealed differences in the %OAT between trials
F1,38 = 19.27, p = 0.0001). Post hoc analysis determined that ani-
als explored the open arms for a shorter time in the second
rial when they had been microinjected with SAL + SAL (p = 0.02),
PA + SAL (p = 0.05) and CPA + HA (p = 0.01). The group that received
AL + HA did not spend less time in the open arms (p = 0.46), and the
OAT was signiﬁcantly different from the CPA + HA group (p = 0.02).
hese results demonstrate that the animals treated with HA did not
void the open arms more during retesting, indicating that the CPA
id not alter behavioral parameters but prevented the histamine-
nduced impairment of memory consolidation.
Table 1 shows the results for all other behaviors. The
NOVA showed no signiﬁcant differences in EAE among groups
F1,38 = 1.54, p = 0.22), which is an EPM index of general exploratory
ctivity. The ANOVA revealed signiﬁcant differences between
rials in OAT (F1,38 = 18.53, p = 0.0001) and OAE (F1,38 = 25.24,
 = 0.00001). Post hoc comparisons indicated that these differ-
nces were present for the groups that were microinjected with
AL + SAL, CPA + SAL, and CPA + HA. Additionally, there were signif-
cant differences between the groups SAL + HA and SAL + SAL (OAE, = 0.03) and between SAL + HA and CPA + HA (OAE, p = 0.004; OAT,
 = 0.02). Furthermore, there were differences between sessions
or EAT (F1,38 = 63.42, p < 0.00001), %EAT (F1,38 = 63.42, p < 0.00001),
T (F1,38 = 14.39, p = 0.0005), total SAP (F1,38 = 7.41, p = 0.01), and
able 2
ffects of the combined injection of the H2 antagonist RA (2.85 nmol) and histamine (4.07
SAL + SAL RA + SAL 
T1 T2 T1 T2 
OAE 6.1 ± 0.9 3.4 ± 1.1 7.2 ± 1.4 4.7 ± 1.4
OAT  120.0 ± 23.3 36.9 ± 15.8* 94.3 ± 21.2 45.9 ± 16
EAE  6.7 ± 0.8 7.4 ± 1.3 9.1 ± 1.3 10.5 ± 1.7
EAT  89.0 ± 15.1 191.1 ± 23.8* 87.7 ± 14.5 176.2 ± 21
%EAT  29.7 ± 5.0 63.7 ± 7.9* 29.2 ± 4.8 58.7 ± 7.3
CT  91.0 ± 10.3 72.2 ± 17.5 118.0 ± 20.5 75.9 ± 16
SAP  7.5 ± 1.0 4.2 ± 0.9 7.5 ± 1.0 6.3 ± 1.8
HD  10.9 ± 3.2 1.4 ± 0.6* 7.3 ± 1.8 2.5 ± 1.3
Immobility 0.0 ± 0.0 0.3 ± 0.3 0.0 ± 0.0 0.4 ± 0.4
he data are presented as the mean values (±SEM). Immediately after exposure to the E
A  + SAL (RA 2.85 nmol/0.1 l and saline), RA + HA (RA 2.85 nmol/0.1 l and HA 4.07 nmol/0
AT  (time spent in the open arms), EAE (number of enclosed arm entries), EAT (time spe
latform time), SAP (frequency of stretched-attend postures), HD (frequency of head di
econd number is the unit measure of time.
* p < 0.05 for Trial 2 versus Trial 1.frequency of head dipping (F1,38 = 36.27, p < 0.00001). The ANOVA
did not detect any signiﬁcant differences in immobility time
(F1,38 = 0.84, p = 0.37) between trials.
3.2. Experiment 2: the effects of pretreatment with the H2
receptor antagonist RA on HA-impairment of memory
consolidation
The two-way ANOVA test revealed that there were no signiﬁcant
differences between the groups in Trial 1 for any of the measures
analyzed (Table 2). However, there were differences in the %OAE
(F1,45 = 15.31, p = 0.0003) between trials. The post hoc analysis indi-
cated that differences in the %OAE existed in groups that were
microinjected with SAL + SAL (p = 0.02) and RA + SAL (p = 0.05). The
animals that received pretreatment with RA (RA + HA) (p = 0.23)
and animals microinjected with SAL + HA (p = 0.21) did not have
a reduced %OAE (Fig. 3A).
Fig. 3B shows the %OAT for the ﬁrst and second sessions. The
ANOVA revealed that there were differences in the %OAT between
sessions (F1,45 = 20.53, p = 0.00005). Duncan’s test indicated that
the animals that were microinjected with SAL + SAL (p = 0.002),
RA + SAL (p = 0.04), and RA + HA (p = 0.03) exhibited a decreased
%OAT in Trial 2 relative to Trial 1. These results indicated that the
H2 antagonist RA, at the dose used in this study, did not have an
effect on memory consolidation and that it failed to prevent entirely
histamine impairment.
 nmol) on the behavior of mice in Trials 1 and 2 in the EPM.
RA + HA SAL + HA
T1 T2 T1 T2
 8.5 ± 1.0 5.7 ± 0.9 7.1 ± 1.4 4.3 ± 0.8
.4* 120.4 ± 19.4 61.3 ± 9.6* 95.5 ± 16.0 77.2 ± 19.3
 8.9 ± 5.4 8.3 ± 1.0 9.1 ± 1.2 9.5 ± 1.4
.8* 89.1 ± 15.4 144.3 ± 20.4* 99.9 ± 15.0 141.4 ± 16.4
* 29.7 ± 5.1 48.1 ± 6.8* 33.3 ± 5.0 47.1 ± 5.5
.9 90.5 ± 12.5 94.4 ± 15.5 104.6 ± 9.8 81.4 ± 13.4
 5.4 ± 1.1 6.6 ± 1.1 7.9 ± 1.1 7.3 ± 1.0
* 5.4 ± 1.2 2.0 ± 0.6 3.3 ± 1.1 3.5 ± 1.1
 0.1 ± 0.1 0.5 ± 0.3 0.0 ± 0.0 0.0 ± 0.0
PM (T1), the animals received a microinjection of the following drugs: SAL + SAL,
.1 l), SAL + HA (saline and HA 4.07 nmol/0.1 l). OAE (number of open arm entries),
nt in the enclosed arms), %EAT (percentage of time in enclosed arms), CT (central
pping), and immobility time. The data are presented as mean values (±SEM). The
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tig. 3. Effects of the combined injection of the H2 antagonist RA (2.85 nmol) and h
ercentage of open arm time (%OAT) in Trials 1 and 2 in the EPM. Data are presente
The ANOVA revealed signiﬁcant differences in the OAT between
rials (F1,45 = 22.33, p = 0.00003). Post hoc comparisons indicated
hat signiﬁcant differences existed for the groups microinjected
ith SAL + SAL (p = 0.001), RA + SAL (p = 0.05), and RA + HA (p = 0.02).
dditionally, differences between sessions for EAT (F1,45 = 31.83,
 = 0.000001), %EAT (F1,45 = 31.83, p < 0.00001), OAE (F1,45 = 11.78,
 = 0.001) and the frequency of head dipping (F1,45 = 19.48,
 = 0.0001) were detected. The ANOVA did not indicate any signiﬁ-
ant differences between trials in the CT (F1,45 = 3.09, p = 0.09), EAE
F1,45 = 24, p = 0.63), immobility time (F1,45 = 3.44, p = 0.07), or total
AP (F1,45 = 1.61, p = 0.21).
. Discussion
The primary ﬁndings of the present study are that pre-treatment
ith the H1 antagonist CPA was able to completely abolish the
ffect on intra-cerebellar histamine impaired emotional memory
onsolidation in mice submitted to the EPM, whereas combined
icroinfusion with the H2 antagonist RA failed to reverse the his-
amine effect.
In the EPM, memory acquired during the ﬁrst exposure is related
o an anxious emotional state. The behaviors expressed during
he test are due to a conﬂict between motivation to explore the
aze and the natural tendency to avoid open spaces (Bertoglio
nd Carobrez, 2000; Lister, 1987). According to File et al. (1990),
fter the initial exploration of the apparatus, rodents acquire,
onsolidate and retrieve some memory related to exploration of
otentially dangerous areas of the maze. Several studies show
hat EPM-experienced animals exhibit a signiﬁcant decrease in
OAE and %OAT during retesting (Bertoglio and Carobrez, 2000;
alvis-Alonso et al., 2010). In a recent study, Gazarini et al. (2011)
emonstrated that pretest and posttest dorsal hippocampus ani-
omycin infusion do not interfere with the further avoidance to
pen arms exhibited by rats in the EPM retest, and according to the
uthors, the test/retest protocol in the EPM is an effective tool that
an be used to investigate memory.
This study conﬁrms our early results, which demonstrated that
nimals microinjected with 4.07 nmol histamine did not explore
he open-arms less during retesting in the EPM, indicating that
istamine has an inhibitory effect on memory (Gianlorenc¸ o et al.,
011a). However, the combined injection with saline (SAL + HA)
nduced a less pronounced effect on memory consolidation, since
here was an absence of a signiﬁcant difference between the control
roup (SAL + SAL) and the group treated with HA.
Histaminergic circuits play a complex role in the mnemonic sys-
em. Histamine has different effects in distinct brain regions and
ay  produce modulatory effects that differ according to mem-
ry type (Benetti et al., 2012; Da Silva et al., 2006; Köhler et al.,
011). Our results show that the histaminergic system may  have
n inhibitory effect in the memory consolidation process with an
nxiety component. The histaminergic projections to the cerebellar
ermis, amygdala and hippocampus can be involved in the modula-
ion of this role. It has been previously proposed that the amygdalaine (4.07 nmol): (A) on the percentage of open arm entries (%OAE) and (B) on the
e mean ± SEM. n = 10–13. *p < 0.05 Trial 2 versus Trial 1, Duncan’s test.
and cerebellum are functionally interconnected during aversive
learning (Turner et al., 2007). According to Sacchetti et al. (2009),
the vermis and amygdala may  interact, and the vermal electrical
stimulation modulates amygdala activity. These effects are medi-
ated by both direct and indirect anatomical connections between
the cerebellum and the limbic areas.
Evidence demonstrates the existence of the histaminergic
receptors H1, H2 and H3 in the cerebellum of rodents (Arrang et al.,
1995; Pollard et al., 1993). Generally, H1 and H2 receptors excite or
potentiate excitatory impulses (Gianlorenc¸ o et al., 2011b; Pollard
et al., 1993), while H3 activation mediates autoinhibition of TMN
neurons (Arrang et al., 1985; Hass and Panula, 2003). According to
a recent review, the H1 receptor is the predominant histaminergic
receptor in the cerebellum (Köhler et al., 2011).
In Experiment 1, the microinfusion of CPA did not alter behav-
ioral parameters by itself, but when CPA was  administrated prior to
HA it reduced the open arm exploration and showed a signiﬁcant
difference from the group that was  microinjected with HA only.
Therefore, pre-treatment with CPA abolished the inhibitory effect
of HA on memory consolidation, which indicates that this receptor
is possibly involved in histamine induced memory impairment.
One possible mechanism to be explored is whether the admin-
istration of the H1 antagonist CPA enhanced histamine levels in the
synaptic cleft and increased the synaptic availability of histamine
and its binding to H3 receptors. Activation of H3 receptors would be
responsible for inhibition of the synthesis and release of endoge-
nous histamine, which reverses the memory impairment. However,
since CPA is not highly selective for H1 receptors, we cannot exclude
the possibility of interactions with other neurotransmitters sys-
tems, such as the serotoninergic and cholinergic systems (Benetti
et al., 2012; Hasenöhrl et al., 1999).
Evidence regarding the role of the histaminergic system in the
learning and memory process is controversial. In addition, the func-
tion of the histaminergic receptors and how they affect the memory
system is still unclear (Köhler et al., 2011). Some studies that inves-
tigated the role of the H1 receptor in memory found that the
intraventricular infusion of CPA improved water maze performance
in aged rats (Hasenöhrl et al., 1999) and improved the one-trial step
through passive avoidance retention (Zarrindast et al., 2002). How-
ever, blockade of the H1 receptor impaired working and reference
memory (Chen et al., 2001). Studies with H1 knockout mice demon-
strated that their inhibitory avoidance performance was unaffected
(Yanai et al., 1998) and that their object recognition performance
was impaired (Daí et al., 2007). In the EPM, systemic CPA did not
have an effect on emotional memory (Gianlorenc¸ o et al., 2011b).
Studies have examined the effects of H2 antagonists on cogni-
tive performance. In the study by Flood et al. (1998),  intra-septal
infusion of dimaprit (H2 agonist) facilitated long-term reten-
tion of an avoidance learning task. The results from Alvarez and
Banzan (2008) demonstrated that pretreatment with RA blocked
the inhibitory effect of histamine on memory consolidation.
Recently, Benetti et al. (2012) suggested that activation of post-
synaptic H2 receptors within the nucleus basalis magnocellularis by
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ndogenous histamine is responsible for the potentiated expres-
ion of fear responses.
In Experiment 2, the H2 antagonist RA did not have an effect
n open arm exploration by itself and when RA was  administered
efore histamine, RA was not able to reverse the inhibitory effect
f histamine on memory. This suggests that H2 receptors in the
erebellar vermis likely do not play a role in the inhibitory effect of
istamine on the EPM.
Emotional memory plays an important role in controlling
ehavior and it is critical for the survival of individuals and of
pecies. An emotional memory deﬁcit could lead to the exposure
f an individual to numerous dangerous situations while the per-
istence of an aversive memory is a considerable factor associated
ith the development of anxiety and fear disorders, including pho-
ias and posttraumatic stress disorder (PTSD). Therefore, in view
f our results, there is a potential importance of these histamine-
odulated effects leading to emotional memory erasure. Further
esearch is warranted to better understand the importance of the
istaminergic system to trauma-related disorders.
. Conclusion
In conclusion, the results of the present study demonstrate that
1 receptors in the cerebellar vermis mediate memory consolida-
ion impairment induced by histamine in mice re-exposed to the
PM.
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